Adam Woodrow, President & Chief Commercial at Paratek Pharmaceuticals, Inc. (PRTK), sold 5,322 shares at $3.82 ($20K) on 2019-10-08, disclosed to the SEC on 2019-10-08.
Scheduled sale ($20k) by President & Chief Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PRTK | SELL | 2022-11-01 | $16K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $269K | — | Filing → |
| PRTK | SELL | 2021-08-18 | $56K | — | Filing → |